Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210886
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2005-09-13
Brief Title:
A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Study Overview
Official Title:
A Multicenter Double-blind Randomized Study to Compare the Efficacy and Safety of Levofloxacin 750 mg Once Daily for Five Days Versus Ciprofloxacin Twice Daily for Ten Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Status:
COMPLETED
Status Verified Date:
2010-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness and safety of two antibiotics in the treatment of complicated urinary tract infection or acute pyelonephritis kidney infection A 5-day course of 750 milligrams of levofloxacin given intravenously andor by mouth once daily will be compared to a 10-day course of 400 milligrams of ciprofloxacin given intravenously andor 500 milligrams of ciprofloxacin given by mouth twice daily
Detailed Description:
Levofloxacin has been approved in both its oral and intravenous forms to treat a large number of infections caused by bacteria Levofloxacin and other members of a class of antibiotics known as fluoroquinolones have been used successfully to treat urinary and kidney infections This study will compare the effectiveness and safety of levofloxacin given for 5 days to that of another fluoroquinolone ciprofloxacin given for 10 days in treating complicated urinary tract infection or acute pyelonephritis kidney infection A shorter course of antibiotics may help patients take all of their medication which is critically important for curing the infection A shorter course may also help prevent the development of bacteria that cannot be killed by antibiotics Patients will take 750 milligrams of levofloxacin intravenously andor by mouth once daily for 5 days or 400 milligrams of ciprofloxacin intravenously andor 500 milligrams of ciprofloxacin by mouth twice daily for 10 days To prevent the study doctor study staff and patients from knowing which study drug they are taking all study drug will manufactured to look the same and patients on the 5-day regimen will be given placebo for the last 5 days of their participation in the study The intravenous infusion bags will be covered so that the solution cannot be seen The objective of the study is to demonstrate that 5 days of levofloxacin once daily is at least as effective as 10 days of ciprofloxacin twice daily in treating complicated urinary tract infection or acute pyelonephritis Patients will take 750 milligrams of levofloxacin intravenously andor by mouth once daily for 5 days or 400 milligrams of ciprofloxacin intravenously andor 500 milligrams of ciprofloxacin by mouth twice daily for 10 days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None